Sponsor: SWOG
Sponsor Study ID: S2015
Study Title: Melanoma Margins Trial (MelMarT II): A Phase III, Multi Centre, Multi National Randomized Control Trial investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
CTO #: 103722
NCT Number: NCT03860883
Phase: III
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Melanoma, Skin
Study Objectives: Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of life.